05/26/2025
11:15 PM | Contineum Therapeutics (Filer)
| Form EFFECT | |
05/14/2025
3:41 PM | Contineum Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/14/2025
3:44 PM | Contineum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2025
3:47 PM | Contineum Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/29/2025
3:53 PM | Contineum Therapeutics (Filer)
| Form ARS | |
04/29/2025
3:14 PM | Contineum Therapeutics (Filer)
| Form DEFA14A | |
04/28/2025
3:10 PM | Contineum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2025
3:08 PM | Contineum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2025
3:10 PM | Contineum Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/06/2025
3:13 PM | Contineum Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2025
9:50 AM | Contineum Therapeutics (Subject)
SECTORAL ASSET MANAGEMENT INC (Filed by)
| Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for CTNM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Contineum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
01/31/2025
3:35 PM | Contineum Therapeutics (Issuer)
Stengone Carmine N. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
3:38 PM | Contineum Therapeutics (Issuer)
Huhn Stephen L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
3:38 PM | Contineum Therapeutics (Issuer)
Lorrain Daniel S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
3:40 PM | Contineum Therapeutics (Issuer)
Slover Peter T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
4:06 PM | Contineum Therapeutics (Issuer)
Lorrain Daniel S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
4:07 PM | Contineum Therapeutics (Issuer)
Lorrain Daniel S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
4:05 PM | Contineum Therapeutics (Subject)
Lorrain Daniel S. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
3:08 PM | Contineum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:10 PM | Contineum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
11:46 AM | Contineum Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SCHEDULE 13G | |
08/14/2024
5:03 PM | Contineum Therapeutics (Issuer)
Huhn Stephen L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
11:46 AM | Contineum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
11:19 AM | Contineum Therapeutics (Filer)
| Form 8-K/A | |
06/24/2024
3:20 PM | Boyce Sarah (Reporting)
Contineum Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/24/2024
3:25 PM | Boyce Sarah (Reporting)
Contineum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy CTNM Stock Free CTNM Stock Alerts